Dysfunctional labor and hemoperitoneum secondary to an incidentally discovered dysgerminoma: a case report.
Case report
Dysgerminoma
Hemoperitoneum
Oophorectomy
Pregnancy
Protracted labor
Staging
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
07 Sep 2021
07 Sep 2021
Historique:
received:
03
02
2021
accepted:
23
07
2021
entrez:
8
9
2021
pubmed:
9
9
2021
medline:
19
11
2021
Statut:
epublish
Résumé
Ovarian dysgerminoma, a subtype of malignant germ cell tumor (GCT), is a rare ovarian neoplasm that is infrequently found in the gravid patient. When dysgerminomas do occur in pregnancy, the rapidly growing tumors can have a heterogeneous presentation and lead to peripartum complications and morbidity. Due to the rarity of this condition, diagnostic and therapeutic strategies are not well described in the literature. A healthy multigravida with an uncomplicated antenatal history presented for elective induction of labor. She had a protracted labor course, persistently abnormal cervical examinations, and eventually developed a worsening Category II tracing that prompted cesarean birth. Intraoperatively, a 26 cm pelvic mass later identified as a Stage IA dysgerminoma was discovered along with a massive hemoperitoneum. The mass was successfully resected, and the patient remains without recurrence 6 months postoperatively. Although rare and generally indolent, dysgerminomas can grow rapidly and cause mechanical obstruction of labor and other complications in pregnancy. Pelvic masses, including malignant neoplasms, should be included in as part of a broad differential diagnosis when evaluating even routine intrapartum complications such as abnormal labor progression. Additionally, we demonstrate that adnexal masses can be a source of life-threatening intraabdominal hemorrhage.
Sections du résumé
BACKGROUND
BACKGROUND
Ovarian dysgerminoma, a subtype of malignant germ cell tumor (GCT), is a rare ovarian neoplasm that is infrequently found in the gravid patient. When dysgerminomas do occur in pregnancy, the rapidly growing tumors can have a heterogeneous presentation and lead to peripartum complications and morbidity. Due to the rarity of this condition, diagnostic and therapeutic strategies are not well described in the literature.
CASE PRESENTATION
METHODS
A healthy multigravida with an uncomplicated antenatal history presented for elective induction of labor. She had a protracted labor course, persistently abnormal cervical examinations, and eventually developed a worsening Category II tracing that prompted cesarean birth. Intraoperatively, a 26 cm pelvic mass later identified as a Stage IA dysgerminoma was discovered along with a massive hemoperitoneum. The mass was successfully resected, and the patient remains without recurrence 6 months postoperatively.
CONCLUSION
CONCLUSIONS
Although rare and generally indolent, dysgerminomas can grow rapidly and cause mechanical obstruction of labor and other complications in pregnancy. Pelvic masses, including malignant neoplasms, should be included in as part of a broad differential diagnosis when evaluating even routine intrapartum complications such as abnormal labor progression. Additionally, we demonstrate that adnexal masses can be a source of life-threatening intraabdominal hemorrhage.
Identifiants
pubmed: 34493243
doi: 10.1186/s12884-021-04063-2
pii: 10.1186/s12884-021-04063-2
pmc: PMC8424888
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
611Informations de copyright
© 2021. The Author(s).
Références
Radiographics. 2014 May-Jun;34(3):777-801
pubmed: 24819795
Obstet Gynecol. 2000 Jan;95(1):128-33
pubmed: 10636515
Arch Gynecol Obstet. 2005 Feb;271(2):104-8
pubmed: 15007601
Oman Med J. 2011 May;26(3):198-200
pubmed: 22043416
Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:145-56
pubmed: 25150953
Gynecol Oncol. 1989 Jun;33(3):326-31
pubmed: 2722058
Am J Obstet Gynecol. 2008 Apr;198(4):357-66
pubmed: 18395031
Gynecol Oncol. 2006 May;101(2):315-21
pubmed: 16310839
Obstet Gynecol. 2006 May;107(5):1075-85
pubmed: 16648414
Curr Opin Obstet Gynecol. 2014 Apr;26(2):49-53
pubmed: 24614018
Am J Obstet Gynecol. 1956 Dec;72(6):1177-9
pubmed: 13372592
J Ultrasound Med. 2009 Oct;28(10):1409-15
pubmed: 19778893
Gynecol Oncol. 1992 Mar;44(3):281-3
pubmed: 1541442
Asia Oceania J Obstet Gynaecol. 1991 Jun;17(2):147-58
pubmed: 1867584
Aust N Z J Obstet Gynaecol. 2006 Feb;46(1):52-4
pubmed: 16441695
J Matern Fetal Neonatal Med. 2013 Jul;26(11):1090-3
pubmed: 23356452
Cancer Biol Ther. 2018 Aug 3;19(8):649-658
pubmed: 29580145